Long-term effects of traumatic stress on subsequent contextual fear conditioning in rats by Ryoke Rie et al.
Long-term effects of traumatic stress on
subsequent contextual fear conditioning in
rats







権利 (C) 2014 Elsevier Inc.
 NOTICE: this is the author’s version of a
work that was accepted for publication in　
Physiology & behavior. Changes resulting from
the publishing process, such as peer review,
editing, corrections, structural formatting,
and other quality control mechanisms may not
be reflected in this document. Changes may
have been made to this work since it was
submitted for publication. A definitive
version was subsequently published in






Long-term effects of traumatic stress on subsequent 











Department of Psychology and Behavioral Neuroscience, University of Tsukuba, Tsukuba, 
Ibaraki 305-8577, Japan 
 
Number of Pages: 22 
Number of Figures: 4 
Number of Tables: 0 
 
Correspondence to: 
*K. Yamada, Ph.D. 
Department of Psychology and Behavioral Neuroscience 




Running head: Long-lasting effects of stress on fear conditioning 
 
Keywords: Contextual fear conditioning, open field behavior, corticosterone, metyrapone, 
post-traumatic stress disorder, contextual reminder, rat 
*Manuscript




Exposure to stressful events affects subsequent sensitivity to fear. We investigated the long-term 
effects of a traumatic experience on subsequent contextual fear conditioning and anxiety-like 
behaviors in rats (Experiment 1). In addition, we tested whether the administration of the 
glucocorticoid synthesis inhibitor metyrapone (MET) attenuated the sensitization of fear 
induced by traumatic stress (Experiment 2). Male rats were subjected to a multiple stress (MS) 
session, which consisted of 4 foot shocks (1 mA, 1 s) and forced swimming for 20 min, 
followed by exposure to a situational reminder 7 days after the MS session. MET (25 or 100 
mg/kg, intraperitoneal) was administered 30 min before MS. The contextual fear conditioning 
was performed 14 days after MS. MS enhanced the conditioned fear response for at least 14 
days after the conditioning, and pretreatment with MET did not affect the enhancement of 
conditioned fear. These results suggest that glucocorticoid secretion triggered by MS is not 
involved in regulating the long-term stress-induced sensitization of fear. 
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1. Introduction 
It is well recognized that stressful or emotionally arousing experiences enhance learning and 
memory. These reactions represent adaptive phenomena aimed at increasing the ability to avoid 
life threat that have been previously encountered. However, the memory of a danger may lead to 
long-lasting behavioral changes. Individuals who have faced traumatic events can often vividly 
retrieve the traumatic experiences to the extent that fright and anxiety are sustained. For 
example, posttraumatic stress disorder (PTSD) is an anxiety disorder that may develop after 
exposure to a strongly traumatic event. 
 
Stress, fear, and anxiety are associated with learning and memory processes in animals [1]. For 
example, Pavlovian fear conditioning is a behavioral paradigm typically used to evaluate the 
strength of aversive memory in rodents [2] and it has been reported that previous exposure to a 
stressful treatment enhances subsequent fear conditioning [3–5]. This phenomenon may 
correspond to the hyper-sensitized reaction observed in patients with PTSD, in whom the 
magnitude of the response is more appropriate to the original traumatizing event than it is to 
current conditions [6]. 
 
Long-term effects of exposure to a single stressor have been reported previously and, the search 
for putative animal models of PTSD has focused on these long-term consequences [7]. A few 
previous studies have reported that a single session of stress can have long-lasting effects, 
including development of anxiety-like behaviors and neurobiological changes. For example, a 
social stress was able to induce long-lasting behavioral changes suggestive of enhanced anxiety 
and depression-like symptoms [8]. In a different study, ketoconazole, an inhibitor of steroid 
synthesis, prevented the long-lasting effects of predator stress on an anxiety-like behavior [9]. 
Pynoos et al. [10], reported that, after a severe shock, mice exposed to a situational reminder 
(without shocks) showed enhanced startle reflexes in an acoustic startle response test. This 
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experimental paradigm was based on the finding that, with the exception of repeated trauma, 
traumatized individuals are often confronted with reminders of the traumatic event, but not with 
the traumatic event itself. The authors suggested that situational reminders of the traumatic 
event contributed to the reactivity in, and chronic aspects of, PTSD [10]. 
 
The biological mechanisms responsible for the stress-induced enhancement of conditioned fear 
have not yet been elucidated. Interestingly, Rau et al. [4] demonstrated that the stress-induced 
enhancement of conditioned fear was not simply the summation or generalization of fear, 
because pre-stress administration of an N-methyl-D-aspartate (NMDA) receptor antagonist 
(which generally prevents memory consolidation and retrieval) did not prevent stress-enhanced 
fear learning. Therefore, it was suggested that enhanced fear memory might not depend on 
associative memory of the traumatic event.  
 
Corticosterone (CORT) is a glucocorticoid that has complex effects on cognitive and emotional 
functions. For example, research in learning and memory has reported that CORT has 
multifaceted actions on memory processes, such as enhancing the acquisition of new 
information and impairing the retrieval of memory [11]. In addition, many studies have 
indicated that administration of CORT can facilitate fear conditioning, while a pre- and 
post-training injection of either a CORT synthesis inhibitor or a glucocorticoid receptor 
antagonist impaired fear conditioning [3,12]. Multiple studies have demonstrated that 
administration of either a glucocorticoid synthesis inhibitor or a glucocorticoid receptor 
antagonist before exposure to restraint stress prevented the anxiogenic effects of the stressor 
[13,14].  
 
It is well established that exposure to stress activates the hypothalamus–pituitary–adrenal (HPA) 
axis, which results in CORT secretion. Therefore, the first aim of the present study was to 
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examine whether a multiple stressor (MS), consisting of foot shocks and forced swimming, had 
long-term effects on anxiety-like behavior and contextual fear conditioning.  Compared to just 
foot shocks or forced swimming, MS strongly affected subsequent conditioned fear in our 
preliminary experiments.  The hypothesis was that the stress-induced secretion of CORT 
during a traumatic event contributes to the post-trauma enhancement of conditioned fear. An 
additional aim was to investigate whether a situational reminder of the traumatic event enhanced 
the effects of the MS. A final goal was to investigate whether pre-MS treatment with 
metyrapone (MET), a glucocorticoid synthesis inhibitor, affected the MS-induced enhancement 
of conditioned fear. The current results suggest that glucocorticoid secretion, triggered by MS, is 
not involved in regulating long-lasting stress-induced behavioral changes. 
2. Material and methods 
2.1 Animals 
Adult male Wistar–Imamichi rats (age range 8–12 weeks) were purchased from the Institute for 
Animal Reproduction (Ibaraki, Japan). Rats were housed in individual cages and maintained on 
a 12 h/12 h light/dark cycle at a controlled ambient temperature (23 ± 1ºC). All experiments 
were carried out according to the guidelines for the Care and Use of Animals approved by the 
University of Tsukuba Committee on Animal Research. 
2.2 Drugs 
The glucocorticoid synthesis inhibitor, 2-methyl-1,2-di-3-pyridyl-1-propanone (metyrapone 
(MET); Sigma-Aldrich, St. Louis, MO USA), was dissolved in a solution of 45% 
2-hydroxypropyl-β-cyclodextrin (HBC; Sigma-Aldrich). MET inhibits enzymatic conversion, 
by 11-beta-hydroxylase, of deoxycorticosterone to CORT, thus inhibiting CORT synthesis and 
subsequent release into the bloodstream. MET (dose: 25 or 100 mg/kg, volume: 1 mL/kg, IP) 
was injected 30 min before the rat was placed in a foot-shock chamber, used to deliver MS. The 
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MET doses were chosen based on previous studies performed in rats exhibiting effects of fear 
conditioning and anxiety-like behavior [15,16]. Control rats received a similar volume of 45% 
HBC solution. 
2.3 Apparatuses 
2.3.1 Multiple stress 
In this study, 2 different shock chambers were used to deliver the electric foot shocks (Context 
A: 30 × 25 × 30 cm, O’Hara & Co., Ltd., Tokyo, Japan) and to conduct the fear conditioning 
(Context B). These chambers differed in their context, including the illumination, background, 
and sound. Electric shocks (used as the MS) were delivered in Context A, which was positioned 
inside a sound-attenuating chamber (100 × 45 × 60 cm, Tech Serv. Inc., MD). The sidewalls 
consisted of opaque black acrylic (Plexiglas, Dow Chemical, Philadelphia, USA) and the back 
and the front walls consisted of clear acrylic (Plexiglas, Dow Chemical) attached to a sheet of 
paper with a black stripe. The lid consisted of clear acrylic placed below an incandescent bulb. 
For the delivery of scrambled shocks, the floor consisted of 19 steel rods (diameter: 5 mm) 
spaced 1.5 cm apart and wired to a shock generator (O’Hara & Co., Ltd.). Forced swimming 
was performed in an opaque-blue plastic bucket (height: 50 cm, diameter: 40 cm). The bucket 
was filled with water to a depth of 30 cm. 
2.3.2 Open field 
The locomotor behavior of rats was videotaped in an open field test (OFT) chamber. The 
chamber was an open-top box (90 × 90 × 45 cm) that consisted of black polyvinylchloride walls 
and a gray floor (O’Hara & Co., Ltd.). The box was illuminated by 4 incandescent bulbs 
installed on the ceiling. The brightness of the center of the floor was 52.5 lx. A video camera 
was placed above the chamber. 
2.3.3 Fear conditioning 
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An automated computer-controlled system (O’Hara & Co., Ltd.) was used in the habituation, 
conditioning, and retention test phases. The fear-conditioning chamber (Context B: 25 × 20 × 30 
cm) was constructed of clear acrylic walls and included a lid with a hole in the center (O’Hara 
& Co., Ltd.). For delivering electric shocks, the Context B chamber was equipped with a grid 
floor made of 16 stainless-steel rods (diameter: 5 mm, 10 mm apart). The chamber was located 
within a sound-attenuating box (70 × 60 × 60 cm; Muromachi Kikai Co., Ltd., Tokyo, Japan) 
with white inside walls and a ventilation fan that provided fresh air, background noise (50 dB), 
and illumination (200 lx). 
2.4 Procedure 
2.4.1 Experiment 1 
2.4.1.1 Multiple stress (MS) 
Rats were randomly assigned to either a MS group or non-stressed (NMS) group . Rats were 
gently transported to the behavioral experimentation room in a stainless-steel black box 
(transportation box, 20 × 40 × 20 cm) that consisted of opaque black walls and lid and an 
opaque-black smooth polypropylene floor. Rats were left in the transportation box for 20 min 
after transportation, prior to placement in the respective testing apparatuses. Rats in the MS 
group were first placed into the Context A chamber. They were left in that for approximately 4 
min, and then received 4 electric foot shocks (1 mA, duration: 1 s) with an inter-shock interval 
that varied from 4-6 min (Total time in Context A: 25 min). The rats in the MS group were then 
placed in the forced swimming chamber and were subjected to forced swimming for 20 min 
immediately after footshocks. Rats in the NMS group were merely exposed to the Context A 
chamber, but did not receive the shocks (Total time in Context A: 25 min). Following Context A, 
NMS rats were then placed into a plastic cage with new bedding (Waiting period, duration: 20 
min). After either forced swimming (MS group) or the waiting period (NMS group), all animals 
were returned to their room in the transportation box. The procedure for this experiment is 
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summarized in Figure 1. 
2.4.1.2 Situational reminder 
Seven days after MS, half of the rats in MS group were exposed to a situational reminder 
(MS+R group) by placing them in the transportation box for 3 min. Finally, 31 animals were 
randomly divided into three groups: NMS (n = 9), MS-R (n = 11), MS+R (n = 11). 
2.4.1.3 Open field test and contextual fear conditioning 
The OFT was performed the day after MS and 23 days after the MS session. On the day of OFT 
testing, each rat was transported in their home cage from the colony room to the OFT room. At 
the start of testing, each rat was placed in the left corner of the arena and its behavior was 
recorded for 10 min. The total distance and time spent in the central and peripheral areas were 
recorded using an automated image analysis software (ImageJ, National Institutes of Health, 
Bethesda, MD USA). Other variables, including the number of rearings, grooming, and 
instances of leaning against the wall, were counted via careful monitoring during the 
observation time. At the end of the observation period, the defecation boli were also counted. 
 
Contextual fear conditioning consisted of habituation, conditioning, and 3 retention tests. Each 
rat was transported in the home cage from the colony room to the fear-conditioning room. In the 
habituation phase, rats were exposed to the Context B chamber for 4 consecutive days, 5 min/d. 
In the conditioning phase (14 d after MS), each rat was placed into the Context B chamber and 
allowed to habituate for 2 min, prior to receiving 2 mild foot shocks (0.1 mA, duration: 2 s, 
inter-shock interval: 1 min). The rat was removed from the Context B chamber immediately 
after the presentation of the second foot shock. In the retention test phase, each rat was again 
placed into the Context B chamber and was kept there for 3 min, without receiving shocks. 
Retention testing took place on the day following the conditioning phase (Retention Test 1) and 
Days 8 (Retention Test 2) and 16 (Retention Test 3) after the conditioning phase. 
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2.4.2 Experiment 2 
The procedures used in Experiment 2 were the same as those used in Experiment 1, with the 
exception that either MET or vehicle (VEH) was administrated before MS and that the OFT was 
not performed. In addition, all rats were subjected to the situational reminder session and blood 
sampling from the tail vein was performed before and after MS treatment. Rats were randomly 
assigned to one of four groups (n=8 per group). Thirty minutes before the MS treatment, MET 
(Dose: 25 or 100 mg/kg) or vehicle (VEH) was injected IP into rats of the MS group 
(MS+MET25, MS+MET100, and MS+VEH). For the NMS group, VEH alone was injected 30 
min before exposure to the context A chamber (NMS+VEH). The procedure for this experiment 
is shown in Figure 1. 
2.5 Quantification of corticosterone 
Since insufficient volume of blood could be obtained from some animals, total 24 blood 
samples, NMS+VEH (n = 7), MS+VEH (n = 6), MS+MET25 (n = 5), MS+MET100 (n = 6), 
underwent the following hormonal assay. The blood collected was allowed to clot at room 
temperature. The serum was obtained by centrifugation at 9,500 rpm and by transferring the 
supernatant to a clean centrifuge tube. The serum was stored at -80ºC until analyzed. The 
procedure was carried out during the light period (1400 to 1800) for 2 days. CORT levels were 
measured using specific enzyme immunoassays (EIA) [17], described below. Each well (ELISA 
Plates 9018; Corning Life Sciences, New York, NY USA) was coated with 100 μL of secondary 
antibody solution (anti-rabbit γ-globulin serum raised in goats, 5 μg/200 μL; Seikagaku Co., 
Tokyo, Japan) and incubated overnight at 4ºC. Unbound antibodies were then removed from the 
wells by emptying and washing 3 times using a plastic pump tube and the plates were inverted 
to dry. Standard CORT (Wako Pure Chemical Industries, Osaka, Japan) was diluted in the assay 
buffer (sodium phosphate buffer, pH 7.2, containing bovine serum albumin at 1 g/L). Aliquots 
of the standard or sample solutions (25 μL), of the antiserum solution (100 μL), and of the 
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labeled steroid hormones (100 μL) were pipetted sequentially into each well. The rabbit 
anti-corticosterone serum (FKA420-E; COSMO Bio, Tokyo, Japan) was diluted 800,000-fold 
with assay buffer. Horseradish-peroxidase-labeled CORT (FKA419) was obtained from 
COSMO Bio. The plates were covered and incubated overnight at 4ºC. Unbound ligands were 
removed and a 150-μL aliquot of the substrate solution for HRP was added to each well and 
incubated for another 50 min at 30ºC. The reaction was stopped by the addition of 50 μL of 
4N-H2SO4. The absorbance at 450 nm of sample and standard solutions was recorded using an 
automatic microplate reader (Bio-Rad model 550, Bio-Rad Laboratories, Hercules, CA USA). 
The results of the assay were calculated using the Microplate Manager III software (Bio-Rad). 
2.6 Statistical analyses 
All data were expressed as mean ± SEM. All statistical analyses were performed using the 
Statistical Program for the Social Sciences (SPSS, IBM Corp., Armonk NY USA). Data were 
analyzed using two-way analysis of variance (ANOVA) or repeated-measures ANOVA. 
Individual comparisons were evaluated using a simple main effect test, a post-hoc Bonferroni’s 
test or Fisher’s PLSD test. 
3. Results 
3.1 Experiment 1 
3.1.1 Open field test 
The OFT was performed on Days 2 and 23 (after MS) for 10 min (Figure 2a). While there was 
no significant main effect for total distance traveled by group (NMS, MS+NR, and MS+R) on 
Day 2, there was a significant main effect on Day 23 [F (2, 28) = 5.29, p < 0.05]. Specifically, 
although the total distance traveled in each of the 3 groups (NMS, MS+NR, and MS+R) was not 
different on Day 2, the MS+R group exhibited a significantly lower total distance traveled on 
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Day 23. In addition, post hoc testing revealed that the total distance traveled by animals in the 
MS+R group was significantly lower than in the NMS group (p < 0.01).  
 
There was a significant main effect for leaning-against-the-wall events by group (NMS, 
MS+NR, and MS+R) on Day 23 [F (2, 28) = 5.62, p < 0.01] (Figure 2b). Post hoc testing 
revealed that the number of leaning-against-the-wall events in the MS+R group was 
significantly lower than that in NMS group (p < 0.05). For Days 2 and 23, there was no 
difference among the groups in terms of the time spent in the central area of the OFT arena. 
3.1.2 Contextual fear conditioning 
The level of freezing in MS+R group was consistently higher across the 3 retention tests, 
compared to the NMS and MS+NR groups (Figure 3). In addition, the MS+NR group exhibited 
a higher level of freezing than the NMS group in Test 1, but not in Tests 2 and 3. There were 
significant main effects of group [F (2, 28) = 5.4, p < 0.05] and trial [F (3, 84) = 30.98, p < 0.01] 
and a significant interaction between group and trial [F (6, 84) = 2.82, p < 0.05] for the 3 groups 
(NMS, MS+NR, and MS+R) during the contextual fear conditioning experiment. Post hoc 
testing showed that, in Tests 1 and 2, the MS+R group had a higher freezing percentage, than 
the NMS group (p < 0.05), but not compared to the MS+NR group. In Test 3, the freezing level 
was significantly higher in the MS+R group compared to both the NMS and MS+NR groups (p 
< 0.05). Moreover, the MS+R group exhibited a significantly higher level of freezing at all 
testing times compared to its baseline (p < 0.05). Finally, in Tests 1 and 2, the MS+NR group 
displayed higher freezing, compared to the baseline (p < 0.05). 
3.2 Experiment 2 
3.2.1 Contextual fear conditioning 
Although animals did not show clear differences between groups (NMS+VEH, MS+VEH, 
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MS+MET25, and MS+MET100) on Retention Test 1 (Figure 4a), the MS-treated groups 
(MS+VEH, MS+MET25, and MS+MET100) showed levels of freezing that were more than 
double that of the NMS+VEH group on Retention Test 2. MET treatment did not affect 
contextual fear conditioning. There were significant main effects of group  [F (3, 28) = 3.14, p 
< 0.05] and trial [F (3, 84) = 69.97, p < 0.01] and an interaction between group and trial [F (9, 
84) = 2.99, p < 0.01] during the contextual fear conditioning experiment. An analysis of simple 
effects indicated that the group effect was significant in both Test 2 [F (3, 28) = 6.34, p < 0.01] 
and Test 3[F (3, 28) = 3.25, p < 0.05]. . Post hoc testing indicated that, in Test 2, the freezing 
levels of the MS+MET25 and MS+MET100 groups were significantly higher than those in the 
NMS+VEH group (p < 0.05), and that the freezing levels of the MS+MET100 group were 
higher than those of the MS+VEH group (p < 0.05). Moreover, in Test 3, MS-treated rats 
showed higher levels of freezing than the NMS+VEH group (p < 0.05). Finally, the freezing 
levels of rats injected with different doses of MET (MS+MET25 and MS+MET100) were not 
significantly different. 
3.2.2 CORT concentration 
Serum CORT levels were significantly elevated after MS treatment (Figure 4b). The 
MS+MET100 group, but not the MS+MET25 group, showed lower levels of CORT after MS. 
There was a significant group effect [F (3, 20) = 7.3, p < 0.01] on the CORT level immediately 
after MS. Post hoc testing indicated that the MS+VEH groups exhibited higher CORT 
concentrations than the NMS+VEH and MS+MET100 groups (p < 0.05). Finally, the 
MS+MET100 group had a significantly lower CORT level, compared to the other groups (p < 
0.05), which indicated a dose-dependent effect of MET on CORT secretion. 
4. Discussion 
The primary findings of this study were that a traumatic experience, consisting of foot shocks 
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and forced swimming, had long-term consequences on stress-related behavioral responses in 
contextual fear conditioning and open field behavior. The results from Experiment 1 
demonstrated that the situational reminder of the MS enhanced these stress-induced behavioral 
changes. In addition, rats exposed to the MS exhibited a higher level of emotional responses in 
an OFT performed 3 weeks after the MS treatment, but not on the same test performed the day 
after the MS. Experiment 2 examined the effects of MET administration (Dose: 25 or 100 
mg/kg) on subsequent fear conditioning, when given immediately before MS. MET treatment 
did not affect the MS-induced enhancement of conditioned fear. Although a high dose of MET 
significantly reduced the post-MS serum CORT concentration, rats in the MS group exhibited 
higher freezing in retention tests 8–15 days after conditioning, compared to rats in the NMS 
group, regardless of drug treatment. 
 
This study demonstrated that the sensitivity to fear, induced by a single session of MS, persisted 
long-term in rats. Because PTSD is characterized by a long-lasting symptomatology, long-term 
behavioral or neurochemical deficits induced by a single session of stressors are more likely 
related to the development of PTSD in animal models. In the current study, enhanced fear 
responses to contextual fear conditioning were shown in rats of the MS group, despite the fact 
that fear conditioning was performed 2 weeks after MS. This result supports results of other 
studies that investigated long-lasting effects of a single traumatic stress in fear learning. For 
example, abnormal behaviors such as unnecessary chamber changes were observed in an active 
escape/avoidance task performed 2 weeks after inescapable foot-shock treatment [18,19]. 
However, it is possible that the increase in responsiveness observed in the active 
escape/avoidance task was caused by the summation of fear of the inescapable foot shocks and 
fear of the active escape/avoidance task, since they were administered using the same apparatus. 
In the current study, contextual fear conditioning was performed in a different apparatus from 
that used to deliver MS, allowing observation of the prolonged sensitization of the fear response 
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to a new aversive stimulus. 
 
Other animal models have been used to show long-term effects on subsequent fear conditioning. 
Liberzon et al. [20,21] proposed a single-prolonged stress (SPS) that produced a sensitization to 
negative feedback in the HPA axis and alteration of hippocampal glucocorticoid receptors 7 or 
14 days after SPS. The SPS animal model exhibited enhanced contextual fear conditioning 7 or 
14 days after the delivery of SPS [22,23]. Rau and Fanselow [5] showed that 15 foot-shocks 
could cause enhancement of fear learning performed 91 days after the delivery of the foot 
shocks. The results of the current study are consistent with these reports. In the present study, in 
addition to the enhancement of fear response in the first retention test, enhanced fear responses 
were demonstrated in both Tests 2 and 3, performed 1 and 2 weeks after conditioning, 
respectively. Thus, these results demonstrate for the first time, that in animals exposed to both 
MS and a situational reminder, enhancement of conditioned fear was maintained for at least 2 
weeks after fear conditioning.  
 
In this study, exposure to the situational reminder was related to an increase in MS-induced 
abnormal behavior. Rats exposed to both MS and a situational reminder showed exaggerated 
response in the OFT and contextual fear conditioning tests, compared to rats only exposed to 
MS (no reminder). These results were consistent with the finding that a single exposure to foot 
shocks followed by situational reminders induced long-lasting effects on anxiety-like behavior 
in rodents [10,24,25]. Pynoos et al. [10] demonstrated that rats that received weekly situational 
reminders for 6 weeks showed a progressive increase in the magnitude of the startle reflex in the 
acoustic startle response test, as well as in aggressive behavior. These results suggest that brief 
exposure to the stress-related context contributes to the maintenance of long-lasting abnormal 
behaviors. Exposure to a stress reminder may be reminiscent of the core symptom of PTSD, 
involuntary re-experiencing of the trauma [26]. 
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The current results showed that MS rats exhibited hypoactivity in the OFT, performed 3 weeks 
after MS, but not when performed immediately after MS. This result may be related to a 
time-dependent sensitization, which is considered a specific clinical symptom of PTSD (i.e., in 
the DSM-IV-TR as “With or Without delayed onset: Onset of symptoms at least 6 months after 
the stressor” [20, 26, 27, 28]. However, it should be noted that contextual fear conditioning 
could cause an exaggeration of anxiety-like behavior in MS rats in the OFT conducted 3 weeks 
after MS. Subsequent fear conditioning had additional anxiogenic effects in the MS group, but 
not on rats in the NMS group, as illustrated by the smaller total distance traveled by the MS 
groups in the second OFT, compared to the first OFT. To determine the time-dependent 
sensitization effect of MS on OFT behavior, future studies should examine whether exaggerated 
anxiety is observed in OFT without fear conditioning in MS rats. 
 
Results from Experiment 2 show that prevention of CORT synthesis after MS treatment did not 
reverse the enhancement of the conditioned fear response. Although MET significantly reduced 
the serum levels of CORT immediately after MS, even the high dose of MET did not influence 
the expression of enhanced fear conditioning. Conversely, although MS-treated rats exhibited a 
higher level of spontaneous freezing than the NMS group on the first day of habituation, rats 
given MET (100 mg/kg) prior to MS exhibited the same amount of freezing as the NMS group 
(data not shown). These results suggest that fear generalization was partially observed in the MS 
group on the first day of habituation. The generalized fear in the MS group was eliminated by 
the administration of MET at a high dose, suggesting that the MS-associated memory was 
disrupted by MET administration. Several studies have suggested that glucocorticoids may be 
involved in learning and memory [29–31]. Therefore, the consolidation of the fear memory of 
the MS itself, but not the MS-induced enhancement of the conditioned fear response, might 
have been modulated by CORT. In addition, although injection of MET prior to MS 
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significantly inhibited MS-induced secretion of CORT, rats treated with MET (100 mg/kg) 
showed almost half level of CORT compared to that of control rats.  Since we could not rule 
out the possibility that half the amount of secretion of CORT observed in MET-treated rats 
caused subsequent enhancement of conditioned fear, further studies using alternative 
manipulations which enable total inhibition of CORT secretion, such as adrenalectomy, will be 
needed. 
 
Unexpectedly, the CORT level of NMS +VEH rats after MS treatment significantly increased 
compared to the basal levels in Experiment 2. Since NMS rats exposed to a shock chamber 
without delivering foot shocks, the elevation of CORT levels in NMS rats may be attribute to 
the exposure to the novel environment. These findings also suggest that MS-induced 
enhancement of conditioned fear is not dependent solely on stress-induced elevation of CORT. 
 
As aversive events lead to physiological stress responses that include the HPA axis and the 
autonomic nervous system, the present study focused on CORT secretion as a key factor 
responsible for behavioral sensitization to traumatic stress [29]. However, MS-induced secretion 
of CORT was not necessary for the long-term enhancement of contextual fear conditioning. As 
previously noted, CORT is involved in widespread responses to stressors, but may be just as a 
modulator of learning and memory related to stress. It is possible that the other stress-related 
hormones or neurotransmitters are capable of encoding and storing traces of traumatic stress and 
that the MS-induced enhancement of conditioned fear will occur. It has been reported that 
aversive events trigger changes in physiological, neuroendocrine, and neuropeptide responses. 
Therefore, additional studies are needed to identify the key substance(s) responsible for 
enhancing the stress-induced fear response.  
5. Conclusion 
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The findings of the current investigation demonstrated that exposure to MS can lead to 
long-term enhancement of a conditioned fear response and to a change in emotionality. 
Moreover, the effects of MS were potentiated by a situational reminder. Although pre-MS MET 
administration impaired contextual memory of the MS itself, it did not prevent the MS-induced 
enhancement of conditioned fear. In conclusion, hyperactivation of the HPA-axis induced by 
traumatic stress does not appear to be essential in subsequent long-term sensitization to mild 
stress. 
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Figure 1. Experimental design. Experiment 1 investigated the effects of a multiple stress (MS) 
and a situational reminder on open field test (OFT) and contextual fear conditioning. 
Experimental 2 investigated the effects of metyrapone prior to MS on the post-trauma 
enhancement of conditioned fear. Baseline blood samples were collected a day before MS. 
 
Figure 2. Effects of multiple stress (MS) on the mean ± SEM (a) total distance traveled and (b) 
number of times the rats leaned against the wall recorded in the open field test (OFT). Rats were 
tested for 10 min on Days 2 and 23 (days after MS session). (a) The MS+R group showed 
reduced open field exploration only on Day 23. (b) The MS+R group showed a reduced number 
of leaning-against-the-wall events only on Day 23. *p < 0.05 
 
Figure 3. Effects of multiple stress (MS) on contextual fear conditioning. MS-treated rats 
showed higher conditional freezing than did rats in the non-multiple stress (NMS) group in Test 
1. The MS+R group showed enhanced freezing in both Tests 2 and 3. *p < 0.05. Data are shown 
as mean ± SEM. 
 
Figure 4. (a) Effects of metyrapone (MET) on contextual fear conditioning. Multiple stress 
(MS)-treated rats had higher conditional freezing than did rats in the non-multiple stress (NMS) 
group. MET administration prior to the MS treatment did not affect the enhancement of 
conditional fear on subsequent fear conditioning. *p < 0.05 compared to NMS+VEH. #p < 0.05 
compared to MS+VEH. (b) Effect of MET injection prior to MS on the corticosterone response 
to MS. Blood samples were taken 1 day before (Baseline) and immediately after MS. The 
increase of the serum corticosterone concentration induced by MS was significantly suppressed 
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